IAM · Forms 3, 4, 5
Insider trades at Iambic Therapeutics
1 insider bought $11.5M of Iambic Therapeutics stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Iambic Therapeutics (IAM) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Catalio Capital Management, LP | 10% owner | Conversion | 1,995,749 | Form 4 | |||
| Catalio Capital Management, LP | 10% owner | Conversion | 1,458,290 | Form 4 | |||
| Catalio Capital Management, LP | 10% owner | Conversion | 742,546 | Form 4 | |||
| R Jacob Vogelstein | Director | Conversion | 1,995,749 | Form 4 | |||
| R Jacob Vogelstein | Director | Conversion | 1,458,290 | Form 4 | |||
| R Jacob Vogelstein | Director | Conversion | 742,546 | Form 4 | |||
| Michael Secora | CFO & Chief Corp Dev Ofcr | Conversion | 61,342 | Form 4 | |||
| William H Rastetter | Director | Conversion | 192,579 | Form 4 | |||
| William H Rastetter | Director | Conversion | 8,341 | Form 4 | |||
| Evan Lockwood Rachlin | Director | Conversion | 1,458,736 | Form 4 | |||
| Evan Lockwood Rachlin | Director | Conversion | 410,762 | Form 4 | |||
| Evan Lockwood Rachlin | Director | Buy | 718,750 | $16.00 | $11.5M | Form 4 | |
| Evan Lockwood Rachlin | Director | Conversion | 57,754 | Form 4 | |||
| Kurt Von Emster | Director | Options or other derivatives | Form 4 | ||||
| R Jacob Vogelstein | Director | Options or other derivatives | Form 4 | ||||
| Mary Tagliaferri | Director | Options or other derivatives | Form 4 | ||||
| Shalini Sharp | Director | Options or other derivatives | Form 4 | ||||
| William H Rastetter | Director | Options or other derivatives | Form 4 | ||||
| Evan Lockwood Rachlin | Director | Options or other derivatives | Form 4 | ||||
| Michael Secora | CFO & Chief Corp Dev Ofcr | Award | 28,400 | Form 4 | |||
| Peter A Olson | Chief Scientific Officer | Award | 19,500 | Form 4 | |||
| Neil Josephson | Chief Medical Officer | Award | 31,000 | Form 4 | |||
| Frederick R Manby | Chief Technology Officer | Award | 132,200 | Form 4 | |||
| Thomas F. Miller | Chief Executive Officer | Award | 132,200 | Form 4 | |||
| Kurt Von Emster | Director | Became an insider (Form 3) | Form 3 | ||||
| R Jacob Vogelstein | Director | Became an insider (Form 3) | Form 3 | ||||
| Mary Tagliaferri | Director | Became an insider (Form 3) | Form 3 | ||||
| Shalini Sharp | Director | Became an insider (Form 3) | Form 3 | ||||
| William H Rastetter | Director | Became an insider (Form 3) | Form 3 | ||||
| Evan Lockwood Rachlin | Director | Became an insider (Form 3) | Form 3 | ||||
| Samit Hirawat | Director | Became an insider (Form 3) | Form 3 | ||||
| Michael Secora | CFO & Chief Corp Dev Ofcr | Became an insider (Form 3) | Form 3 | ||||
| Peter A Olson | Chief Scientific Officer | Became an insider (Form 3) | Form 3 | ||||
| Neil Josephson | Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| Frederick R Manby | Chief Technology Officer | Became an insider (Form 3) | Form 3 | ||||
| Thomas F. Miller | Chief Executive Officer | Became an insider (Form 3) | Form 3 |
1 more filing still loading from EDGAR; this page refreshes within minutes.
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.